BCAR4 is known as breast cancer anti-oestrogen-resistance 4, and was recently reported as a metastasis-stimulating lncRNA in breast cancer.17,34 However, the oncogenic effects of BCAR4 fusion in lung cancer have not been identified. This evidence concerns the gene BCAR4 and breast carcinoma.